Clinical Trials Browser

cilgavimab and tixagevimab drug combination × Other hematologic neoplasm × Clear all

NCT05465876 2024-04-04

PACE-CLL

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05438498 2023-09-08

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Phase 3 Terminated

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms